Key facts
- This page summarizes Gregory J. Herrema's Form 4 filing for Telesis Bio Inc. (TBIO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 May 2024, 19:10.
Gregory J. Herrema - 01 May 2024 Form 4 Insider Report for Telesis Bio Inc. (TBIO)
- Reporting relationship
- Director
- Issuer ticker
- TBIO
- Reported as of
- 01 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 May 2024, 19:10:03 UTC
- Prior SEC filing
- 25 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rob Cutler, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Gregory J. Herrema filed Form 4 for Telesis Bio Inc. (TBIO) on 03 May 2024.
Change
- Previous filing in this sequence was filed on 25 Oct 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TBIO
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +31,486
- Change %
- +21%
- Price
- $0.000000
- Shares after
- 184,677
- Date
- 01 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TBIO
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +30,362
- Change %
- Price
- $0.000000
- Shares after
- 30,362
- Date
- 01 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,362
- Exercise price
- $0.3557
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through each applicable date, 11,245 of the RSUs shall vest on January 1, 2025, and 20,241 of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.
Footnote F2
Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.